Sphere Fluidics (SF) is an established Life Sciences company providing single-cell-analysis and monoclonality-assurance systems for biotherapeutic discovery and development. The Company has a portfolio of 79 patents (40 granted), 16 registered trademarks and 32 products comprising of hardware, software and consumables.
Cyto-Mine®, underpinned by the Company’s patented picodroplet technology, integrates selective screening of tens-of-millions of single cells, sorting, isolation and clone verification into an automated platform. This streamlines workflows, reduces costs and improves throughput to enable high-value clones to be captured in a single run.
